Search Results - Lew, R.

Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents by Shaw, J., Andrianopoulos, N., Duffy, S., Walton, A., Clark, D., Lew, R., Sebastian, M., New, G., Brennan, A., Reid, Christopher, Ajani, A.

Get full text

Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry by Yan, B., Ajani, A., New, G., Duffy, S., Farouque, O., Shaw, J., Sebastian, M., Lew, R., Brennan, A., Andrianopoulos, N., Reid, Christopher, Clark, D.

Get full text

Rates of Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents (from a Large Australian Multicenter Registry) by Yan, B., Duffy, S., Clark, D., Lefkovits, J., Warren, R., Gurvitch, R., Lew, R., Sebastian, M., Brennan, A., Andrianopoulos, N., Reid, Christopher, Ajani, A.

Get full text

Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents by Freeman, M., Clark, D., Andrianopoulos, N., Duffy, S., Lim, H., Brennan, A., Charter, K., Shaw, J., Horrigan, M., Ajani, A., Sebastian, M., Reid, Christopher, Farouque, H., Duffy, S., Shaw, J., Walton, A., Farrington, C., Gunaratne, R., Broughton, A., Federman, J., Keighley, C., Dart, A., Clark, D., Johns, J., Horrigan, M., Farouque, O., Oliver, L., Brennan, J., Chan, R., Proimos, G., Dortimer, T., Chan, B., Tonkin, A., Brown, L., Champbell, N., Sahar, A., Charter, K., New, G., Roberts, L., Liew, H., Rowe, M., Proimos, G., Cheong, N., Goods, C., Lew, R., Szto, G., Templin, R., Black, A., Sebastian, M., Yip, T., Ponnuthrai, L., Rahmen, M., Dyson, J., Duplessis, T., Krum, H., Reid, C., Brennan, A., Meehan, A., Loane, P., Curran, L., Groen, F., Szto, G., O'Shea, V., Ajani, A., Warren, R., Eccleston, D., Lefkovits, J., Yan, B., Roy, P., Shetty, S., Gurvitch, R., Lim, Y., Eccleston, D., Walton, A.

Get full text